CD274 and melanoma: Moreover, one study has shown that PD-L1 expression on non-classical (CD14dimCD16+) and intermediate (CD14+CD16+) monocytes is significantly increased in patients and is associated with efficacy of melanoma patients treated with anti-PD-1 immunotherapy [191].